Related references
Note: Only part of the references are listed.C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results
Renee C. Prins et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
C-reactive protein-associated genetic variants and cancer risk: Findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies
Katriina Heikkila et al.
EUROPEAN JOURNAL OF CANCER (2011)
Associations between adipokines and obesity-related cancer
Gilberto Paz-Filho et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation
Mieke Van Hemelrijck et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer
Sharon R. Pine et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Circulating C-Reactive Protein Concentrations and Risks of Colon and Rectal Cancer: A Nested Case-Control Study Within the European Prospective Investigation into Cancer and Nutrition
Krasimira Aleksandrova et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Genetic variation in RNASEL associated with prostate cancer risk and progression
Mara S. Meyer et al.
CARCINOGENESIS (2010)
Soluble adhesion molecules in human cancers: Sources and fates
Jeroen W. J. van Kilsdonk et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2010)
C-Reactive Protein and Risk of Lung Cancer
Anil K. Chaturvedi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk
C. M. Eklund et al.
BRITISH JOURNAL OF CANCER (2009)
Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis
Katriina Heikkilae et al.
CANCER CAUSES & CONTROL (2009)
C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older
Brandon L. Pierce et al.
CANCER CAUSES & CONTROL (2009)
Genetic variation in adipokine genes and risk of colorectal cancer
Sonali Pechlivanis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality
Jennifer Rider Stark et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Adipokine genes and prostate cancer risk
Steven C. Moore et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients
Brandon L. Pierce et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer
Kristine H. Allin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
What Do Case-Control Studies Estimate? Survey of Methods and Assumptions in Published Case-Control Research
Mirjam J. Knol et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Intercellular adhesion molecule-1 genetic markers (+241G/A and+469A/G) in Iranian women with breast cancer
Nargess Arandi et al.
CANCER GENETICS AND CYTOGENETICS (2008)
Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk
Virginia G. Kaklamani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies
Sang-Ah Lee et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Correlation between the serum values of soluble intercellular adhesion molecule-1 and total sialic acid levels in patients with breast cancer
M. Basoglu et al.
EUROPEAN SURGICAL RESEARCH (2007)
A systematic review of the association between circulating concentrations of C reactive protein and cancer
Katriina Heikkila et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2007)
C-reactive protein levels, variation in the c-reactive protein gene, and cancer risk: The Rotterdam Study
Claire Siemes et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
ICAM gene cluster SNPs and prostate cancer risk in African Americans
Hankui Chen et al.
HUMAN GENETICS (2006)
Inflammation, a key event in cancer development
HT Lu et al.
MOLECULAR CANCER RESEARCH (2006)
C-reactive protein levels and subsequent cancer outcomes: Results from a prospective cohort study
KJ Helzlsouer et al.
EUROPEAN JOURNAL OF CANCER (2006)
Plasma C-reactive protein and risk of cancer: A prospective study from Greece
D Trichopoulos et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Low plasma adiponectin levels and risk of colorectal cancer in men: A prospective study
EK Wei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort
D Il'yasova et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
From blood monocytes to adipose tissue-resident macrophages -: Induction of diapedesis by human mature adipocytes
CA Curat et al.
DIABETES (2004)
Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus
S Kammerer et al.
CANCER RESEARCH (2004)
Inflammation as a tumor promoter in cancer induction
M Philip et al.
SEMINARS IN CANCER BIOLOGY (2004)
The SU.VI.MAX study -: A randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals
S Hercberg et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer
EA Platz et al.
PROSTATE (2004)
C-reactive protein: a critical update
MB Pepys et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Chronic inflammation as inductor of pro-cancer microenvironment: Pathogenesis of dysregulated feedback control
PM Schwartsburd
CANCER AND METASTASIS REVIEWS (2003)
Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma
DM O'Hanlon et al.
EUROPEAN JOURNAL OF CANCER (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Serum soluble vascular cell adhesion molecule-1: Role as a surrogate marker of angiogenesis
GJ Byrne et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)